Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Core Laboratories (CLB) over the last 4 years, with Q3 2025 value amounting to $14.2 million.

  • Core Laboratories' Operating Expenses rose 1659.97% to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.1 million, marking a year-over-year increase of 2813.32%. This contributed to the annual value of $54.2 million for FY2024, which is 240.13% down from last year.
  • As of Q3 2025, Core Laboratories' Operating Expenses stood at $14.2 million, which was up 1659.97% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Core Laboratories' Operating Expenses registered a high of $17.2 million during Q1 2025, and its lowest value of $3.7 million during Q4 2023.
  • Its 4-year average for Operating Expenses is $9.1 million, with a median of $8.2 million in 2022.
  • In the last 5 years, Core Laboratories' Operating Expenses tumbled by 911.91% in 2023 and then skyrocketed by 29360.24% in 2024.
  • Over the past 4 years, Core Laboratories' Operating Expenses (Quarter) stood at $3.9 million in 2022, then fell by 4.05% to $3.7 million in 2023, then skyrocketed by 236.89% to $12.6 million in 2024, then grew by 12.65% to $14.2 million in 2025.
  • Its Operating Expenses stands at $14.2 million for Q3 2025, versus $14.0 million for Q2 2025 and $17.2 million for Q1 2025.